BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

British Journal of Ophthalmology 2008;92:617-622; doi:10.1136/bjo.2007.130286
Copyright © 2008 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Shields, C L
Right arrow Articles by Shields, J A
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shields, C L
Right arrow Articles by Shields, J A
Topic Collections
Right arrowRelated Article

CLINICAL SCIENCE

Autofluorescence of choroidal melanoma in 51 cases

C L Shields, C Bianciotto, C Pirondini, M A Materin, S A Harmon, J A Shields

Ocular Oncology Service, Wills Eye Institute, Thomas Jefferson University, Philadelphia, PA, USA

Correspondence to:
Dr C L Shields, Ocular Oncology Service, Suite 1440, Wills Eye Institute, 840 Walnut Street, Philadelphia, PA 19107, USA; carol.shields{at}shieldsoncology.com

Aim: To describe the autofluorescence features of choroidal melanoma.

Design: Non-comparative case series.

Participants: 51 consecutive patients.

Methods: Standard fundus photography and autofluorescence photography (580 nm excitation, 695 nm barrier filter) were performed on all patients. Clinical features were correlated with autofluorescence features.

Main outcome measure: Autofluorescence features of choroidal melanoma and overlying retinal pigment epithelium (RPE).

Results: The mean patient age was 59 years. The choroidal melanoma was a mean of 3.6 mm from the optic disc and 2.6 mm from the foveola. The mean tumour basal dimension was 11 mm and the mean tumour thickness was 4 mm. The choroidal melanoma showed intrinsic hypoautofluorescence (39%), isoautofluorescence (6%) and hyperautofluorescence (55%). Slightly increased hyperautofluorescence of the melanoma was found in pigmented tumours (versus non-pigmented), those with greater thickness and basal dimensions, and those with overlying disrupted RPE. Related RPE hyperplasia and atrophy showed hypoautofluorescence, drusen, RPE detachment and subretinal fluid showed slight hyperautofluorescence, and orange pigment displayed the brightest hyperautofluorescence.

Conclusions: Choroidal melanoma generally shows slight intrinsic hyperautofluorescence and the brightness increases with pigmented tumours, larger tumours, and those associated with disrupted RPE. Overlying orange pigment shows remarkably bright hyperautofluorescence.


CLS has had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

Funding: Support provided by the Retina Research Foundation of the Retina Society in Cape Town, South Africa to CLS), the Paul Kayser International Award of Merit in Retina Research, Houston, TX (to JAS), a donation from Michael, Bruce, and Ellen Ratner, New York, NY (to JAS, CLS), Mellon Charitable Giving from the Martha W Rogers Charitable Trust, Philadelphia, PA (to CLS), the LuEsther Mertz Retina Research Foundation, New York, NY (to CLS), and the Eye Tumour Research Foundation, Philadelphia, PA (to CLS, JAS). The sponsors did not participate in the design or conduct of this study, in the collection, analysis or interpretation of the data, or in the preparation, review or approval of the manuscript.

Competing interests: None declared.


Related Article

At a glance
Harminder S Dua and Arun D Singh
Br. J. Ophthalmol. 2008 92: 585. [Extract] [Full Text] [PDF]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2008 by the BMJ Publishing Group Ltd.